Compare BIPC & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIPC | MMED |
|---|---|---|
| Founded | 2019 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.7B |
| IPO Year | 2019 | 2025 |
| Metric | BIPC | MMED |
|---|---|---|
| Price | $36.94 | $23.48 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $45.00 | $22.56 |
| AVG Volume (30 Days) | 886.5K | ★ 1.6M |
| Earning Date | 04-29-2026 | 06-03-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,102,000,000.00 |
| Revenue This Year | $7.85 | $15.99 |
| Revenue Next Year | $5.94 | $10.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 14.25 |
| 52 Week Low | $34.18 | $10.65 |
| 52 Week High | $51.72 | $24.43 |
| Indicator | BIPC | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 34.71 | 76.98 |
| Support Level | $34.18 | $10.68 |
| Resistance Level | $42.84 | N/A |
| Average True Range (ATR) | 0.88 | 1.12 |
| MACD | -0.29 | 0.29 |
| Stochastic Oscillator | 20.79 | 91.13 |
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.